Dr. Naveen Kumar Bade, MD

Dr. Bade practices at Nephrology and Hypertension Consultants in Anniston, Alabama.

Dr. Bade's NPI, 1518340454, was assigned on July 8, 2015. Dr. Bade holds Alabama license 37316.

Dr. Bade's primary practice is Nephrology and Hypertension Consultants, at 522 E 11th St, Anniston, AL 36207 in Calhoun County. The practice phone is (256) 237-5302.

Dr. Bade's primary practice is Nephrology and Hypertension Consultants in Anniston, Alabama. Dr. Bade is also affiliated with Regional Medical Center. The medical group on file is Nephrology and Hypertension Consultants. Dmand AI also links Dr. Bade to 2 more hospitals, 4 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bade practices, 8 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Bade's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Bade is licensed in Alabama.

CMS data shows 2,023 Medicare services from Dr. Bade across 13 procedure codes in 2024, for 541 Medicare patients. Medicare paid $171,686 for them.

CMS counts 541 Medicare patients who saw Dr. Bade in 2024. The largest group is 75 to 84, with 206 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 21% are also on Medicaid. Their average risk score is 3.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bade's median patient age at 71, with 56% women.

In 2024, Dr. Bade wrote 2,111 Medicare Part D claims for 452 patients. 86% of them were for generic drugs. CMS names the drug for 1,857 of them, across 39 drugs with 11 or more claims each, at $271,523 in total drug cost. In 2023, CMS named 1,466 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Bade for performance year 2024, reported as part of a group. Dr. Bade accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Bade, published from 2014 to 2025. Dr. Bade's most frequent co-authors are Dana V. Rizk, Bharath Jakka, MD and John K. Maesaka, MD.

CMS Open Payments shows 229 general payments to Dr. Bade from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Amgen Inc. paid the most, $650.